A huge effort by all subdivisions of our company has made it possible to achieve a significant breakthrough: the antibiotic Zevtera was included in the List of Vital and Essential Drugs (VED). This success is not only a key milestone in the development of the company, but is also of great importance for the entire healthcare sector.
JSC Lancet makes public the launch of a new project: the information and education platform "Eduzdrav.ru" for members of management of state and private healthcare institutions of the Russian Federation.read more...
The Lancet company completed the first shipment of medicinal products to Georgia. Within the framework of the concluded agreement, Georgian partners received Takhokomb medical sponges which are used in surgery to prevent blood loss. It was the first experience of such foreign cooperation for the company.read more...
November 19, 2021, Moscow - In the rating of the largest Russian companies RBC 500, compiled summarizing the results of 2020, the pharmaceutical industry showed steady growth – its total revenue increased by 21.7%, amounting to 1.3 trillion rubles. read more...
11 November 2021 Moscow. - Lancet JSC has increased sales of blood management products, including anticoagulants, by more than 20 %, and preparations for anaesthesiology and resuscitation by 7.4 % in 9 months of 2021 compared to the same period of 2020, and has strengthened its leadership at the Russian market in these areas. read more...
Mainstream analytical agencies have summarized the operation of pharma companies during nine months of 2020 and have determined the market leaders. read more...
Preliminary results of the Project “Effective in-patient hospital” were presented at the Congress “Control and prevention of healthcare-associated infections (HAI-2019)” with international participation which took place in Moscow.read more...
Lancet has become a partner at research-to-practice conference on respiratory tract diseases of Northwestern Federal District of Russia with international participation. read more...
Lancet JSC expresses heartfelt congratulations to radiologists on their professional holiday, as well as its partners on international educational project in the field of radiology - European Society of Radiology (ESR) and European School of Radiology (ESOR).read more...
At the first IACMAC Eurasian Congress on Antimicrobial therapy and clinical microbiology the results of the project “Effective in-patient hospital” implemented by Lancet PLC in cooperation with the partner non-governmental organization “Russian Sepsis Forum” were reported. read more...
90 years ago a life-changing for humanity discovery was made by British bacteriologist Alexander Fleming who afterwards was justly called one of the hundred most prominent people of the XX century. read more...
Lancet supported holding of the XII International Conference on Microcirculation and Hemorheology, which was held in Yaroslavl on July 1-3, 2019.read more...
The choice of Kazan to open a new office of Lancet JSC is due to the high potential not only of the city, but of the entire Republic of Tatarstan and the Volga Federal District (VFD), as well as the strong and stable position of the company in the region. At the end of 2018, Lancet became one of the leaders in terms of public procurement in the Volga Federal District, taking the 3rd place among pharmaceutical distributors with a market share of 8.2%.read more...
On the eve of Children's Day, employees of Lancet JSC collected gifts for pupils of Petropavlovsk children’s home located in the Omsk Region.read more...
European Society of Radiology in partnership with “Lancet” organized regular educational course “Asklepios Course. Oncologic imaging” in Sochi, 14 – 15 May 2015read more...
ChemRar High Tech Center (ChemRar), the Russian pharmaceutical investment and R&D group, and Lancet, Russian Distribution Company, have announced collaboration for research, development and commercialization of new medicines in Russia with the intention to stimulate the innovative development of the Russian pharmaceutical industryread more...
RBC annually publishes Russian fast growing companies’ ratings. This year Lancet is included in “RBC top-30: Growth champions” for the first time.read more...
An antithrombotic workshop called “White Nights in St. Petersburg”, being a part of the cycle of scientific activities of the National Scientific Society “Inflammation”, was held in St. Petersburg on March 16, 2014, with the support of Lancet.read more...
The all-Russia conference with international participation “The strategy and tactics of complicated ischemic heart disease treatment” took place on the 6th of June 2014 in Cheboksary.read more...
The VII Extraordinary Nevsky Radiological Forum “NRF 2014”, one of the largest scientific congresses in Russia, concluded its three-day work on April 6, 2014 in St. Petersburg. This forum was dedicated to the 100th anniversary of the Regional Public Organization “St. Petersburg Radiology Association”, being the first professional association for radiology in Russia and one of the first in the world.read more...
Regular workshop for doctors “Antiplatelet Agents in General Practice” organized by the National Scientific Society Inflammation was held on March 15, 2014 in Moscow with the support of Lancet.read more...
A webinar on the “Tactics of managing pregnant women with RBC sensitization at the stage of antenatal clinics” was held for the obstetricians and gynecologists of the outpatient clinics of the Moscow Department of Healthcare on February 12, 2014, within the framework of the distance education program.read more...
The XIX All-Russian Congress of Cardiovascular Surgeons took place at the Bakoulev Center for Cardiovascular Surgery of the Russian Academy of Medical Sciences.read more...
Russian National Congress of Cardiology was taking place in St. Petersburg from 25 to 27 September 2013. Speakers from 34 countries participated in the Congress; more than 5,000 physicians attended the Congress events.read more...
Dear partners,
We are glad to inform you that a branch of Lancet was opened on the 4th of July 2013 in Novosibirsk. The third office of the Company will increase the operational efficiency of its work in three regions of Russia — the Ural region, Siberia and the Far East.read more...
TCT Russia – the 16th Moscow International Course on Endovascular Therapies was taking place in Moscow on June 9 – 11, 2013. As in 2012, when the event was held in Russia for the first time, it was organized by the Cardiovascular Research Foundation (CRF, USA) and Russian Scientific Society of Endovascular Therapies.read more...
